Nektar Therapeutics has split its stock 2 times since its initial public offering (IPO). The first stock split occurred on August 23, 2000 with the ratio of 2-for-1, meaning that for 1 share of NKTR owned pre-split, shareholders then owned 2 shares. The most recent stock split took place on June 09, 2025 on a 1-for-15 basis.
These actions have increased NKTR stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only change the number of shares and the price per share with no impact on Nektar Therapeutics's total market capitalization.
For more detailed information of Nektar Therapeutics's stock splits, view the table below:
The answer will depend on the decisions of the company's managers and market volatility. Nektar Therapeutics has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when NKTR stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Nektar Therapeutics's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
